Searched for
BRISTOL MYERS NEWS
'No discussions' over AstraZeneca-Bristol Myers deal, senior source saysAstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was eve...- US President Donald Trump to announce new deals to lower drug prices, White House saysPresident Trump is set to announce new agreements Friday aimed at lowering prescription drug prices, with major drugmakers like AbbVie, Bri...
- Wall Street ekes out modest gains as S&P 500 hovers near all-time closing highU.S. stocks closed slightly higher in languid trading on Wednesday, with little market-moving news to fuel conviction as the S&P 500 hovere...
- Nasdaq leads Wall St higher as Microsoft hits record highAt 11:37 a.m. ET, the Dow Jones Industrial Average was up 104.08 points, or 0.30%, at 35,051.36, the S&P 500 was up 19.87 points, or 0.44%,...
- Warren Buffett's Berkshire reveals three new secret buysThe Apple stake reduction left Berkshire with a holding valued at about $120 billion at the end of 2020, according to another filing. The i...
- View: Warren Buffett likes stocks againThe disclosure of Berkshire’s Pfizer holding — valued at $138 million as of Monday’s close — comes a week after the drugmaker announced tha...
- Nikkei falls to 15-month low as Fed outlook knocks sentimentTakeda had sunk to a six-year low of 3,498 yen on Wednesday after a ratings downgrade by Moody's.
- Nikkei ends at 8-week low, US FX comments hit automakers; Softbank sinksThe Nikkei share average ended 1.8 per cent lower at 22,271.30.
- Nikkei edges up to new 27-year high as weaker yen fans earnings hopesThe Nikkei share average ended 0.1 per cent higher at 24,270.62
- Cipla climbs 3% on USFDA approval to HIV drugThe stock rose 3.27 per cent to hit a high of Rs 622 on BSE.
- New drug approves immunotherapy for Cancer treatmentMerck’s competitors have lined up their own immunotherapy drugs. They include Bristol Myers Squibb (BMS), Roche & Novartis & several smalle...
- BDR Pharma seeks cancer drug licenceBDR Pharma has filed an application with the Mumbai Patent Office, seeking compulsory licence to market a crucial cancer drug, dasatinib
- Biocon enters in partnership with Bristol-Myers Squibb; stock upThe stock has been in an uptrend this week and has moved nearly 5% higher, while for the month of November Biocon surged over 16%.
- Bristol-Myers offers $3.5 bn for Amylin: ReportsShares of Amylin Pharmaceuticals Inc rose as much as 51 percent as the company rejected a $3.5 billion unsolicited takeover bid from Bristo...
- Jeremy Levin named as next CEO of Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries Ltd named Jeremy Levin of Bristol-Myers Squibb Coto to replace Shlomo Yanai as chief executive officer.
- Piramal denies takeover bid by GlaxoGlaxoSmithKline is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for around $1.5 billion.
- Glaxo in talks for Pirmal HealthcareBritish pharma major GlaxoSmithKline Plc is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for arou...
- Oil rises slightly after sharp drop overnightOil prices rose slightly Friday in Asia after a sharp decline overnight as investors mulled how much the global economic slowdown will damp...
- Liberal arts grads succeed in businessFor a small school with a liberal arts bent, Hamilton College in rural upstate New York does quite well with recruiters, particularly from ...
- Firms ready with cheaper HIV drugsThe single once-a-daily pill will make the treatment cheaper and easier as against struggling with dozens of pills in a day.
Load More
